Literature DB >> 11980876

Expression of pigment epithelium-derived factor in experimental choroidal neovascularization.

Reem Z Renno1, Ayman I Youssri, Norman Michaud, Evangelos S Gragoudas, Joan W Miller.   

Abstract

PURPOSE: To investigate the expression of pigment epithelium-derived factor (PEDF) in the rat laser-injury model of choroidal neovascularization (CNV).
METHODS: Retinas were immunostained for PEDF at different times (1, 2, and 3 weeks) after laser injury. Levels of PEDF protein in the vitreous at 1, 3, 7, 14, and 28 days after laser injury were also assayed by Western blot.
RESULTS: Protein levels of PEDF in the vitreous were increased during the first 7 days after CNV induction. Immunostaining for PEDF was observed throughout normal nonlasered control retinas, sham-lasered retinas, and areas remote to laser lesions, which were generally more intense in the outer nuclear layer (ONL) and less intense in the internal nuclear layer (INL). Decreased expression of PEDF was observed in flanking areas adjacent to the injury site and was confined mainly to the ONL. In the injury sites, immunostaining within the ONL was either absent or decreased for up to 3 weeks after laser injury (the duration of the study). Preadsorption of the anti-PEDF antibody with the immunizing peptide blocked specific labeling in the retina.
CONCLUSIONS: These results demonstrate an inverse correlation of expression of PEDF and formation of CNV in the experimental model and suggest that decreased expression of PEDF plays a permissive role in the formation of CNV. PEDF analogues may be a reasonable treatment strategy for CNV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980876

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

Review 1.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 2.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

3.  Inhibition of choroidal neovascularization by lentivirus-mediated PEDF gene transfer in rats.

Authors:  Ya-Jie Yu; Bin Mo; Lu Liu; Yan-Kun Yue; Chang-Li Yue; Wu Liu
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

4.  Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents.

Authors:  Sara Moghaddam-Taaheri; Monica Agarwal; Juan Amaral; Irina Fedorova; Elvira Agrón; Norman Salem; Emily Chew; S Patricia Becerra
Journal:  J Clin Exp Ophthalmol       Date:  2011-10-23

5.  Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration.

Authors:  Haibo Wang; Erika S Wittchen; M Elizabeth Hartnett
Journal:  Eye Brain       Date:  2011-09-27

Review 6.  Role of growth factors and the wound healing response in age-related macular degeneration.

Authors:  Reinier O Schlingemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

Review 7.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

8.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy.

Authors:  M Matsuoka; N Ogata; T Otsuji; T Nishimura; K Takahashi; M Matsumura
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

9.  Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium.

Authors:  Gottfried Martin; Günther Schlunck; Lutz L Hansen; Hansjürgen T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-14       Impact factor: 3.117

10.  Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization.

Authors:  Juan Amaral; S Patricia Becerra
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.